FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Enter into Agreement

  • Home
  •  | 
  • Tag Archives: "Enter into Agreement"

Granite Creek Copper and Copper North Mining Corp. Enter into Data-Sharing Agreement

Granite Creek Copper and Copper North Mining Corp. Enter into Data-Sharing Agreement
April 1, 2019 Granite Creek Copper Ltd. (TSX.V: GCX) (“Granite Creek”) and Copper North Mining Corp. (TSX.V: COL) (“Copper North”) (the “Companies”) are pleased to announce they have entered into a comprehensive data-sharing agreement (the “Agreement”), with respect to existing mineral exploration data on the companies’ adjoining mineral claims in the Carmacks Copper District of Canada’s Yukon Territory.
Read more

Nutritional High Enters Into Asset Purchase Agreement in Washington

Nutritional High Enters Into Asset Purchase Agreement in Washington
Jan. 03, 2019 (GLOBE NEWSWIRE) -- Nutritional High International ("Nutritional High" or the "Company") (CSE: EAT, OTCQB: SPLIF, FRANKFURT:2NU) is pleased to announce that it has entered into an Asset Purchase Agreement (the "Agreement"), as amended on December 26, 2018, between its wholly-owned Nevada subsidiary (the "Subsidiary"), and a Washington limited liability company (the "Seller"), pursuant to which the Subsidiary will acquire assets and certain IP brands from the Seller.
Read more

Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer

Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer
Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, is pleased to announce that the Company has entered into an exclusive license agreement with the University of Washington (UW) in Seattle to develop a cannabinoid-based product for the treatment of glioblastoma multiform and brain metastases. The program, developed in the lab of renowned cannabis researcher Dr. Nephi Stella, founder and co-director of the UW Center for Cannabis Research, includes a lead therapeutic, ST-403. Pascal plans to begin human clinical studies of ST-403 in 2019.
Read more